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background: Quantification of heart failure (HF)-free survival in the context of risk factor burden in mid-life may improve risk 
communication and prevention efforts.
Methods: We conducted a pooled, individual-level survival analysis from the Framingham Heart, Framingham Offspring, Chicago Heart 
Association Detection Project in Industry, and Atherosclerosis Risk in Communities studies. All participants were free of cardiovascular 
disease at baseline. We used a modified Kaplan-Meier analysis adjusted for competing risk of death and Irwin’s Restricted Mean to 
estimate the overall and HF-free survival in participants with and without hypertension (HTN: BP ≥140/90 mmHg or treatment), obesity 
(BMI ≥30Kg/m2), or diabetes (DM: fasting glucose ≥126 mg/dL or treatment), and combinations of these factors, at an index age of 45 
years through age 95.
Results: During 471,988 person years of follow-up, 1449 incident HF events occurred. Men and women without HTN, obesity, or DM lived 
on average 35.3 and 37.0 years without incident HF respectively. Compared to participants with no risk factors, those with HTN, obesity, 
and or DM at baseline had shorter HF-free survival (3 to 11 years). Men and women without HTN, obesity, or DM at age 45 years lived on 
average 11.3 to 12.7 years longer free of HF than those with all three risk factors.
conclusion: Reduction in HTN, obesity, and DM prevalence by age 45 years may substantially prolong HF-free survival, reduce HF-related 
morbidity, and reduce the public health impact of HF. 
